From http://projects.propublica.org/docdollars. © Copyright 2013 Pro Publica Inc.
Novartis
Based in Basel, Switzerland, Novartis makes prescription and generic drugs, eye care products, vaccines and diagnostics. In September 2010, Novartis agreed to pay $420 million to settle allegations of improper marketing of six drugs. It pleaded guilty to a misdemeanor of off-label promotion involving Trileptal as an anti-epileptic drug.
Novartis reports payments to physicians for speaking and speaker training after October 2010. Its first report covers the period of October 2010 to September 2011. Its second report, which covers the following 12 months, includes meals, travel, consulting, educational items, research and speaking fees. It does not report information by calendar year.
See all Novartis payments, or visit Novartis's transparency page.
Notable drugs
- Diovan/Co–Diovan (hypertension)
- Gleevec (chronic myeloid leukemia)
- Zometa (cancer complications)
- Ritalin/Focalin (attention deficit/hyperactive disorder)
- Reclast/Aclasta (osteoporosis)
- Gilenya (relapsing multiple sclerosis)
- Exelon/Exelon Patch (alzheimer’s disease)
- Exforge (hypertension)
- Cataflam (non-steroidal anti-inflammatory drug)
- Clozaril (treatment-resistant schizophrenia)
Payment Reports
2010 Oct. to 2011 Sept.
| Avg. Quarterly | Total | |
|---|---|---|
| Speaking | $24,830,517 | $24,830,517 |
| $24,830,517 | $24,830,517 |
2011 Oct. to 2012 Sept.
| Avg. Quarterly | Total | |
|---|---|---|
| Speaking | $16,537,077 | $16,537,077 |
| Meals | $5,882,787 | $5,882,787 |
| Travel | $3,319,314 | $3,319,314 |
| Consulting | $2,993,572 | $2,993,572 |
| Items, Gifts | $603,789 | $603,789 |
| $29,336,539 | $29,336,539 |
Total Payments by State
| State | Total |
|---|---|
| California | $5,505,204 |
| New York | $5,031,558 |
| Texas | $3,571,184 |
| Florida | $3,095,700 |
| Ohio | $2,861,675 |
| Pennsylvania | $2,709,134 |
| New Jersey | $2,531,338 |
| Illinois | $2,293,528 |
| North Carolina | $2,228,688 |
| Michigan | $2,209,341 |
| Maryland | $2,083,551 |
| Missouri | $1,647,654 |
| Massachusetts | $1,377,535 |
| Georgia | $1,360,948 |
| Tennessee | $1,317,860 |
| Virginia | $1,230,784 |
| Colorado | $949,598 |
| Indiana | $936,921 |
| South Carolina | $819,894 |
| Wisconsin | $709,597 |
| Washington | $702,363 |
| Alabama | $691,652 |
| Louisiana | $644,935 |
| Connecticut | $641,515 |
| Kentucky | $547,765 |
| Minnesota | $452,780 |
| Arizona | $442,823 |
| Puerto Rico | $430,612 |
| Oregon | $430,490 |
| Iowa | $394,220 |
| Oklahoma | $333,859 |
| Nevada | $327,381 |
| New Hampshire | $305,418 |
| Mississippi | $298,676 |
| Kansas | $289,241 |
| West Virginia | $278,723 |
| Utah | $270,827 |
| North Dakota | $261,896 |
| Rhode Island | $259,219 |
| New Mexico | $235,539 |
| Nebraska | $219,732 |
| Idaho | $211,965 |
| Arkansas | $170,022 |
| Hawaii | $152,802 |
| District of Columbia | $135,405 |
| Vermont | $128,777 |
| Delaware | $107,098 |
| South Dakota | $104,183 |
| Montana | $69,250 |
| Alaska | $64,167 |
| Maine | $63,556 |
| Wyoming | $27,758 |
| [Unknown State] | $249 |
What Companies Disclose
See which services pharmaceutical companies report paying health practitioners for.
Big Pharma’s Big Fines
Drug companies have paid billions to the Department of Justice to resolve allegations of health care fraud. See some of the biggest settlements.
